SAR 99
The Isotretinoin (Roaccutane) Package is designed to monitor your health throughout isotretinoin treatment by evaluating liver function, kidney function, cholesterol levels, and overall blood health. These tests help healthcare providers ensure that the treatment remains safe and detect any potential side effects at an early stage
ALT is a liver enzyme that helps assess liver health. Elevated ALT levels may indicate liver inflammation or medication-related liver injury, making this test essential during isotretinoin therapy.
Another liver enzyme used to assess overall liver function.
Its elevation along with ALT indicates liver involvement or hepatocellular damage.
The ALT/AST ratio provides additional information about liver health and helps physicians interpret changes in liver enzyme levels during treatment.
The blood urea test evaluates how well the kidneys remove waste products from the body. Abnormal results may indicate reduced kidney function and should be monitored during treatment.
Creatinine is a key marker of kidney function. Measuring creatinine helps determine how efficiently the kidneys filter waste from the bloodstream.
The eGFR estimates the kidneys’ filtering capacity and is one of the most important indicators of kidney health. A reduced eGFR may suggest impaired kidney function.
A CBC measures red blood cells, white blood cells, hemoglobin, and platelets. It provides an overview of general health and helps detect changes that may occur during isotretinoin treatment.
HDL, commonly known as “good cholesterol,” helps remove excess cholesterol from the bloodstream. Monitoring HDL is important because isotretinoin may affect lipid levels.
LDL, often referred to as “bad cholesterol,” can build up in the arteries when elevated.
Regular monitoring helps assess cardiovascular risk during Isotretinoin treatment
سيتم التواصل معك من قبل وريد لتاكيد الحجز
سيتم التبرع بجزء من قيمة الفاتورة عبر منصة إحسان قدامك العافية
